Westhampton Capital LLC Lowers Stock Holdings in The Clorox Company (NYSE:CLX)

Westhampton Capital LLC lessened its position in The Clorox Company (NYSE:CLXFree Report) by 2.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 23,797 shares of the company’s stock after selling 559 shares during the quarter. Clorox makes up 2.0% of Westhampton Capital LLC’s investment portfolio, making the stock its 11th largest holding. Westhampton Capital LLC’s holdings in Clorox were worth $3,877,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of the company. Innealta Capital LLC purchased a new stake in Clorox during the second quarter worth about $30,000. Trifecta Capital Advisors LLC lifted its holdings in Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares in the last quarter. GoalVest Advisory LLC acquired a new stake in Clorox during the 1st quarter worth approximately $31,000. First Foundation Advisors purchased a new position in Clorox in the 1st quarter valued at approximately $31,000. Finally, Family Firm Inc. acquired a new position in shares of Clorox in the second quarter worth $31,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on CLX shares. TD Cowen began coverage on Clorox in a research note on Tuesday, July 23rd. They issued a “sell” rating and a $122.00 price objective on the stock. Deutsche Bank Aktiengesellschaft increased their price target on Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. DA Davidson reissued a “neutral” rating and set a $153.00 price objective on shares of Clorox in a research report on Friday, September 6th. Evercore ISI reduced their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Finally, Barclays boosted their price target on shares of Clorox from $130.00 to $137.00 and gave the stock an “underweight” rating in a report on Friday, October 11th. Six equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, Clorox has a consensus rating of “Hold” and a consensus target price of $150.14.

Get Our Latest Stock Analysis on CLX

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 0.51% of the company’s stock.

Clorox Trading Down 0.7 %

NYSE CLX opened at $159.23 on Wednesday. The firm’s fifty day moving average price is $159.96 and its 200 day moving average price is $145.33. The Clorox Company has a 12 month low of $114.68 and a 12 month high of $169.09. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The company has a market capitalization of $19.77 billion, a price-to-earnings ratio of 82.50, a price-to-earnings-growth ratio of 3.19 and a beta of 0.41.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The company had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. On average, sell-side analysts expect that The Clorox Company will post 6.64 earnings per share for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.06%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 252.85%.

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

See Also

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.